Literature DB >> 17533368

TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.

V Lehen'kyi1, M Flourakis, R Skryma, N Prevarskaya.   

Abstract

The transient receptor potential channel, subfamily V, member 6 (TRPV6), is strongly expressed in advanced prostate cancer and significantly correlates with the Gleason >7 grading, being undetectable in healthy and benign prostate tissues. However, the role of TRPV6 as a highly Ca(2+)-selective channel in prostate carcinogenesis remains poorly understood. Here, we report that TRPV6 is directly involved in the control of prostate cancer cell (LNCaP cell line) proliferation by decreasing: (i) proliferation rate; (ii) cell accumulation in the S-phase of cell cycle and (iii) proliferating cell nuclear antigen (PCNA) expression. We demonstrate that the Ca(2+) uptake into LNCaP cells is mediated by TRPV6, with the subsequent downstream activation of the nuclear factor of activated T-cell transcription factor (NFAT). TRPV6-mediated Ca(2+) entry is also involved in apoptosis resistance of LNCaP cells. Our results suggest that TRPV6 expression in LNCaP cells is regulated by androgen receptor, however, in a ligand-independent manner. We conclude that the upregulation of TRPV6 Ca(2+) channel in prostate cancer cells may represent a mechanism for maintaining a higher proliferation rate, increasing cell survival and apoptosis resistance as well.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533368     DOI: 10.1038/sj.onc.1210545

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  86 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  Suppression of aberrant transient receptor potential cation channel, subfamily V, member 6 expression in hyperproliferative colonic crypts by dietary calcium.

Authors:  Sara Peleg; Joseph H Sellin; Yu Wang; Michael R Freeman; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

Review 3.  Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance.

Authors:  Koichi Inoue; Zaven O'Bryant; Zhi-Gang Xiong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 4.  Calcium wave signaling in cancer cells.

Authors:  Jai Parkash; Kamlesh Asotra
Journal:  Life Sci       Date:  2010-09-25       Impact factor: 5.037

5.  Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels.

Authors:  Christopher B Phelps; Robert J Huang; Polina V Lishko; Ruiqi R Wang; Rachelle Gaudet
Journal:  Biochemistry       Date:  2008-01-31       Impact factor: 3.162

6.  Regulation of the Ca(2+) channel TRPV6 by the kinases SGK1, PKB/Akt, and PIKfyve.

Authors:  Mentor Sopjani; Anja Kunert; Kamil Czarkowski; Fabian Klaus; Jörg Laufer; Michael Föller; Florian Lang
Journal:  J Membr Biol       Date:  2009-12-30       Impact factor: 1.843

Review 7.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 8.  Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Authors:  I Azimi; S J Roberts-Thomson; G R Monteith
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway.

Authors:  Kathleen C Brown; Ted R Witte; W Elaine Hardman; Haitao Luo; Yi C Chen; A Betts Carpenter; Jamie K Lau; Piyali Dasgupta
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

10.  Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.

Authors:  Zongtao Lin; Srinivasa R Marepally; Tae-Kang Kim; Zorica Janjetovic; Allen Sw Oak; Arnold E Postlethwaite; Linda K Myers; Robert C Tuckey; Andrzej T Slominski; Duane D Miller; Wei Li
Journal:  Anticancer Res       Date:  2016-03       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.